Your browser doesn't support javascript.
loading
A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors.
Goulding, John; Yeh, Wen-I; Hancock, Bryan; Blum, Robert; Xu, Tianhao; Yang, Bi-Huei; Chang, Chia-Wei; Groff, Brian; Avramis, Earl; Pribadi, Mochtar; Pan, Yijia; Chu, Hui-Yi; Sikaroodi, Shohreh; Fong, Lauren; Brookhouser, Nicholas; Dailey, Thomas; Meza, Miguel; Denholtz, Matthew; Diaz, Evelyn; Martin, Judy; Szabo, Peter; Cooley, Sarah; Ferrari de Andrade, Lucas; Lee, Tom T; Bjordahl, Ryan; Wucherpfennig, Kai W; Valamehr, Bahram.
Afiliação
  • Goulding J; Fate Therapeutics Inc., San Diego, CA 92131, USA. Electronic address: bobby.goulding@fatetherapeutics.com.com.
  • Yeh WI; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Hancock B; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Blum R; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Xu T; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Yang BH; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Chang CW; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Groff B; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Avramis E; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Pribadi M; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Pan Y; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Chu HY; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Sikaroodi S; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Fong L; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Brookhouser N; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Dailey T; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Meza M; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Denholtz M; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Diaz E; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Martin J; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Szabo P; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Cooley S; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Ferrari de Andrade L; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Lee TT; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Bjordahl R; Fate Therapeutics Inc., San Diego, CA 92131, USA.
  • Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Neurology, Brigham & Women's Hospital, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
  • Valamehr B; Fate Therapeutics Inc., San Diego, CA 92131, USA. Electronic address: bob.valamehr@fatetherapeutics.com.
Med ; 4(7): 457-477.e8, 2023 Jul 14.
Article em En | MEDLINE | ID: mdl-37172578
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article